Epalrestat

SKU: orb1308563

Description

Epalrestat (ONO-2235) is a well-tolerated aldose reductase inhibitor for long-term research use. It effectively alleviates symptoms and slows the progression of diabetic neuropathy in preclinical models, particularly under conditions of good glycemic control. Its application extends to in vitro enzyme assays and in vivo studies of diabetic complications.

Research Area

Neuroscience

Key Properties

• CAS Number: 82159-09-9
• MW: 319.40
• Purity: >98%
• Formula: C₁₅H₁₃NO₃S₂
• SMILES: CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O
• Target: Reductase
• Solubility: Soluble in DMSO (up to 5 mg/ml).

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

ONO-2235

Compound Identifiers

PubChem CID

1549120